نتائج البحث - Adrian Bloor

تنقيح النتائج
  1. 1
    Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center

    Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single... حسب Adam Gibb, C. Jones, Adrian Bloor, S. Kulkarni, Tim Illidge, Kim Linton, John Radford

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host disease

    Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host disease حسب Kilian Kelly, Adrian Bloor, James E. Griffin, Rohini Radia, David T Yeung, John E.J. Rasko

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    High Response Rate to Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Indolent Non-Hodgkin Lymphoma

    High Response Rate to Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Indolent Non-Hodgkin Lymphoma حسب Adrian Bloor, Kirsty Thomson, Noha Chowdhry, Stephanie Verfuerth, Stuart J. Ings, Ronjon Chakraverty, David C. Linch, Anthony H. Goldstone, Karl S. Peggs, Stephen Mackinnon

    منشور في 2007
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma

    Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma حسب Kirsty Thomson, Emma Morris, Adrian Bloor, Gordon Cook, Don Milligan, Anne Parker, Fiona Clark, Lynny Yung, David C. Linch, Ronjon Chakraverty, Karl S. Peggs, Stephen Mackinnon

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    T-Cell–Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patients With Multiply Relapsed Follicular Lymphoma

    T-Cell–Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patient... حسب Kirsty Thomson, Emma Morris, Don Milligan, Anne Parker, Ann E. Hunter, Gordon Cook, Adrian Bloor, Fiona Clark, Majid Kazmi, David C. Linch, Ronjon Chakraverty, Karl S. Peggs, Stephen Mackinnon

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Response of ETV6-FLT3–positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3

    Response of ETV6-FLT3–positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3 حسب Christoph Walz, Philipp Erben, Michael Ritter, Adrian Bloor, Georgia Metzgeroth, Nick Telford, Claudia Haferlach, Torsten Haferlach, Stefan Gesk, Joannah Score, Wolf‐Karsten Hofmann, Andreas Hochhaus, Nicholas C.P. Cross, Andreas Reiter

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study

    Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation... حسب Adrian Bloor, Amit Patel, James E. Griffin, Maria Gilleece, Rohini Radia, David T Yeung, Diana Drier, Laurie S. Larson, Gene I. Uenishi, Derek J. Hei, Kilian Kelly, Igor I. Slukvin, John E.J. Rasko

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Multicentre adaptive randomised trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin versus calcineurin inhibitor-based or sirolimus-based post-transplant cyclophosphamide (Methods of T cell Depletion, MoTD trial)

    Multicentre adaptive randomised trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin versus calcineurin inhibitor-based or sirolimu... حسب Ronjon Chakraverty, Emma Kempshall, Fiona L. Dignan, Adrian Bloor, Matthew Collin, Kavita Raj, Jeff Davies, Victoria Potter, Ram Malladi, Siobhán Smith, Simon Gates, Charlotte Gaskell, Rebecca Bishop, Andrea Hodgkinson, G.C. Smith

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma

    Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma حسب Claire Roddie, Lorna Neill, Wendy Osborne, Sunil Iyengar, Eleni Tholouli, David Irvine, Sridhar Chaganti, Caroline Besley, Adrian Bloor, Ceri Jones, Ben Uttenthal, Rod Johnson, Robin Sanderson, Kathleen Cheok, Maria A. V. Marzolini, William Townsend, Maeve O’Reilly, Amy A. Kirkwood, Andrea Kühnl

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies

    Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies حسب Annalisa Paviglianiti, Annalisa Ruggeri, Fernanda Volt, Guillermo Sanz, Nöel Milpied, Sabine Fürst, Albert Esquirol, William Arcese, Alessandra Picardi, Christelle Ferrà, Norbert Ifrah, Jean Henri Bourhis, Kavita Raj, Peter A. von dem Borne, Simona Sica, Anne‐Lise Ménard, Adrian Bloor, Chantal Kenzey, Éliane Gluckman, Vanderson Rocha

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia – a matched pair analysis by the Acute Leukaemia Working Party of EBMT

    Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia – a matched pair analysis by the Acute Leukaemia Working Party of EBMT حسب Christoph Schmid, Myriam Labopin, Nicolaas Schaap, Hendrik Veelken, Michael Schleuning, Michael Stadler, Jürgen Finke, Erin Hurst, Frédéric Baron, Olle Ringdén, Gesine Bug, Didier Blaise, Johanna Tischer, Adrian Bloor, Jordi Esteve, Sebastian Giebel, Bipin N. Savani, Norbert Claude Gorin, Fabio Ciceri, Mohamad Mohty, Arnon Nagler

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study

    Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study حسب Peter Hillmen, Andy C. Rawstron, Kristian Brock, S Munoz-Vicente, Francesca Yates, Rebecca Bishop, Rebecca H. Boucher, Donald Macdonald, Chris Fegan, Alison M. McCaig, Anna Schuh, Andrew R. Pettitt, John G. Gribben, Piers Patten, Stephen Devereux, Adrian Bloor, Christopher P. Fox, Francesco Forconi, Talha Munir

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia

    Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia حسب Christoph Schmid, Myriam Labopin, Nicolaas Schaap, Hendrik Veelken, Arne Brecht, Michael Stadler, Jürgen Finke, Frédéric Baron, Matthew Collin, Gesine Bug, Per Ljungman, Didier Blaise, Johanna Tischer, Adrian Bloor, Alexander Kulagin, Sebastian Giebel, Norbert Claude Gorin, Jordi Esteve, Fabio Ciceri, Bipin N. Savani, Arnon Nagler, Mohamad Mohty

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution

    Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution حسب Ronjon Chakraverty, Guillermo Ortí, Sy Ha, Jun Shen, Adele K. Fielding, Panagiotis Kottaridis, Donald Milligan, Matthew Collin, Charles Crawley, Peter Johnson, Andrew Clark, Anne Parker, Adrian Bloor, Ruth Pettengell, John A. Snowden, Andrew R. Pettitt, Richard E. Clark, G Hale, Karl S. Peggs, Kirsty Thomson, Emma Morris, Stephen Mackinnon

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

    Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Stu... حسب Carmen Martı́nez, Jorge Gayoso, Carmen Canals, Hervé Finel, Karl S. Peggs, Alida Dominietto, Luca Castagna, Boris V. Afanasyev, Stephen Robinson, Didier Blaise, Paolo Corradini, Maija Itälä‐Remes, Arancha Bermúdez, Édouard Forcade, Domenico Russo, Michael Potter, Grant McQuaker, Ibrahim Yakoub‐Agha, Christof Scheid, Adrian Bloor, Silvia Montoto, Peter Dreger, Anna Sureda

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post‐<scp>BCR</scp>inhibitor setting: a<scp>UK</scp>wide analysis

    Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post‐<scp>BCR</scp>inhibitor setting: a<scp>UK</scp>wide analysis حسب Toby A. Eyre, Amy A. Kirkwood, Satyen H. Gohil, George Follows, Renata Walewska, Harriet S. Walter, Matt Cross, Francesco Forconi, Nimish Shah, Richard Chasty, Alistair Hart, Angus Broom, Helen Marr, Piers Patten, Andy Dann, Arvind Arumainathan, Tal Munir, Shankara Paneesha, Adrian Bloor, Rosalynd Johnston, Kim Orchard, Anna Schuh, Christopher P. Fox

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party

    Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party حسب Olaf Penack, Christophe Peczynski, Christian Koenecke, Emmanuelle Polge, Andrea Kühnl, Nathalie Fégueux, Michael Daskalakis, Nicolaus Kröger, Peter Dreger, Caroline Besley, Urs Schanz, Adrian Bloor, Arnold Ganser, Édouard Forcade, Lucía López‐Corral, Jakob Passweg, Urban Novak, Ivan Moiseev, Hélène Schoemans, Grzegorz Basak, Christian Chabannon, Anna Sureda, Diana Averbuch, Bertram Glaß, Rafael de la Cámara, Zinaida Perić

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    <scp>NCRI</scp> phase <scp>II</scp> study of <scp>CHOP</scp> in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome

    <scp>NCRI</scp> phase <scp>II</scp> study of <scp>CHOP</scp> in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome حسب Toby A. Eyre, Ruth Clifford, Adrian Bloor, Lucy Boyle, Corran Roberts, Maité Cabes, Graham P. Collins, Stephen Devereux, George Follows, Christopher P. Fox, John G. Gribben, Peter Hillmen, Chris S.R Hatton, Tim Littlewood, Helen O. McCarthy, J. A. H. Murray, Andrew R. Pettitt, Elizabeth J. Soilleux, Basile Stamatopoulos, Sharon Love, Andrew Wotherspoon, Anna Schuh

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study

    Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study حسب Neema P. Mayor, James Hayhurst, Thomas R. Turner, Richard Szydlo, Bronwen E. Shaw, Will P. Bultitude, Jex-Ray Sayno, Franco Tavarozzi, Katy Latham, Chloe Anthias, James Robinson, Henny Braund, Robert Danby, Julia Perry, Marie C. Wilson, Adrian Bloor, I. Grant McQuaker, Stephen Mackinnon, David I. Marks, Antonio Pagliuca, Michael Potter, Victoria Potter, Nigel H. Russell, Kirsty Thomson, J. Alejandro Madrigal, Steven G. E. Marsh

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

    Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia حسب Claire Roddie, Juliana Dias, Maeve O’Reilly, Mahnaz Abbasian, Amaia Cadiñanos-Garai, Ketki Vispute, Leticia Bosshard‐Carter, Marina Mitsikakou, Vedika Mehra, Harriet Roddy, John A. Hartley, Victoria J. Spanswick, Helen L. Lowe, Bilyana Popova, Laura Clifton‐Hadley, Graham Wheeler, Joanna Olejnik, Adrian Bloor, David Irvine, L. Wood, Maria A. V. Marzolini, Sabine Domning, Farzin Farzaneh, Mark W. Lowdell, David C. Linch, Martin Pulè, Karl S. Peggs

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: